Altos Labs

Overview

Develops medicines based on cell rejuvenation, using computation, machine learning, and internal and external biological data to study cell health, disease, injury, and disability.

Timeline

1. Dec 2025series-b · $1.5B · led by Yuri Milnertheinformation.com ↗